Aegerion Pharma (AEGR) Announces Approval of Juxtapid in Japan as HoFH Treatment
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/25/2024
Go back to Aegerion Pharma (AEGR) Announces Approval of Juxtapid in Japan as HoFH Treatment
September 28, 2016 4:45 PM EDT
Aegerion Pharma (NASDAQ: AEGR) is gaining 33% after-hours after the company announced that Japans Ministry of Health, Labor & Welfare (MHLW) has approved JUXTAPID for patients with homozygous familial hypercholesterolemia (HoFH).
...
More